As of Aug 28
| +0.25 / +0.41%|
The 10 analysts offering 12-month price forecasts for Integra LifeSciences Holdings Corp have a median target of 71.50, with a high estimate of 80.00 and a low estimate of 55.00. The median estimate represents a +17.62% increase from the last price of 60.79.
The current consensus among 15 polled investment analysts is to Hold stock in Integra LifeSciences Holdings Corp. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.